It was selected for the further in vitro and in vivo assessment based on its high inhibitory activity against PDE4 and PDE7 tested in vitro, and a profound TNFα-inhibitory potency assessed in a rat model of LPS-induced endotoxemia [25]. The gene discussed is PDE7A; the disease is serum lipopolysaccharide activity.